Article
Nifedipine Does Not Alter the Pharmacokinetics of Venlafaxine Enantiomers in Healthy Subjects Phenotyped for CYP2D6, CYP2C19, and CYP3A.
Journal of clinical pharmacology - 1 Mar 2021
Tozatto Eduardo, Benzi Jhohann Richard de Lima, Rocha Adriana, Coelho Eduardo Barbosa, Lanchote Vera Lucia
Abstract excerpt
Venlafaxine (VEN) is a P-glycoprotein (P-gp) substrate, and nifedipine has been described by in vitro and experimental studies as a P-gp inhibitor. The present study aimed to investigate whether nifedipine alters the kinetic disposition of VEN enantiomers and their metabolites in healthy subjects. A crossover study was conducted in 10 healthy subjects phenotyped as extensive metabolizers for cytochrome P450 (CYP)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
